Clinical Trial Update: Vericiguat for Heart Failure With Reduced Ejection Fraction After Myocardial Infarction

View source ↗

Summary

A clinical trial update indicates a study evaluating vericiguat for heart failure with reduced ejection fraction after myocardial infarction is not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction
• Myocardial Infarction

Drugs mentioned

• Vericiguat (vericiguat)

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: HFrEF - Heart Failure With Reduced Ejection Fraction, Myocardial Infarction (MI) | Status: NOT_YET_RECRUITING